1 / 10

Glioblastoma Multiforme (GBM) – Subtype Analysis

Glioblastoma Multiforme (GBM) – Subtype Analysis. Lance Parsons. Introduction. Clinicians (meat readers) determine histological categorization: Astrocytoma, Oligodendrocytoma, Mixed, or Glioblastoma multiforme (GBM) GBM patients have poor prognosis, but some surive unexpectly long.

paley
Télécharger la présentation

Glioblastoma Multiforme (GBM) – Subtype Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Glioblastoma Multiforme (GBM) – Subtype Analysis Lance Parsons

  2. Introduction • Clinicians (meat readers) determine histological categorization: Astrocytoma, Oligodendrocytoma, Mixed, or Glioblastoma multiforme (GBM) • GBM patients have poor prognosis, but some surive unexpectly long. • Molecularly and clinically distinct subtypes of GBMs

  3. Tumor Type Age Astro Mixed Oligo GBM Young Medium Old Gene Subset Expression X Y X Glioma Subtypes A B C Survival Short Long Incorporating Biological Knowledge • “Tiers” of classification can assist with discovery of downstream groups • Glioma Classification • Histological Level • Clinical Level (Survival, Age, etc) • Transcriptiome (Gene Expression Level) • Gene Classification • GO Hierarchy • Pathway Databases • Expression Level (Microarray Data)

  4. Age and Survival • Young patients show greater variability in survival • Use this level of the “hierarchy” to assist in downstream analysis. • Very simple method is to use only the Young samples and find the groups within that set of samples.

  5. Normalization • Making the numbers comparable • Log Transform – Equalize variance, lineraize data • Median Center Arrays – Correct for differences between arrays • Standardize to unit variance?

  6. Noise Filter • Removing noise from the dataset • Affymetrix software does some of this with Present/Absent calls • Fold-change filter? • Other methods?

  7. Feature (Gene) Selection • Find genes highly correlated with patient survival, within young sample group. • Cox Proportional Hazards model • Regression model that accounts for “censored” data • Permutation test can improve robustness • Simple Cox selects 39 genes (permutation pending)

  8. Exploration of Results • The genes we select are statistically significant (as dictated by our Cox testing methodology), but they may not be biologically or clinically significant. • Initial exploration through hierarchical clustering.

  9. Clinical Validation • Kaplan-Meier curves fit the two groups to a survival model

  10. Biological Validation • file:///C:/Documents%20and%20Settings/Lance/My%20Documents/Research/projects/HenryFord/HFAnalysis-GBM-Young_annotations.html

More Related